Associated Papers
EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.
Liu ZK et al.
Molecular Cancer, 2021
34044846 (PubMed )
Supplement: 12943_2021_1377_MOESM2_ESM.zip › Additional_file_2-Table_S3.xlsx › Splice_Site_and_silent
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
Yan T et al.
Nature Communications, 2019
30975989 (PubMed )
Supplement: 41467_2019_9255_MOESM4_ESM.xlsx › Supplementary_Data_2a
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Kim SY et al.
Oncotarget, 2015
25831047 (PubMed )
Supplement: oncotarget-06-7597-s002.xlsx › Table_S1
Select a paper to view details